Single Intranasal Administration of Ucn3 Affects the Development of PTSD Symptoms in an Animal Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211908 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Andrej Tillinger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center of the Slovak Academy of Sciences, Institute of Experimental Endocrinology, 845 05 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Urocortins, Stress Disorders, Post-Traumatic, Administration, Intranasal, Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VEGA.
Abstract (Originalsprache)
Post-traumatic stress disorder (PTSD) is a multifactorial psychological disorder that affects different neurotransmitter systems, including the central CRH system. CRH acts via the CRHR1 and CRHR2 receptors, which exert opposite effects, i.e., anxiogenic or anxiolytic. The aim of this work was to investigate how intranasal administration of the CRHR2-specific agonist urocortin 2 (Ucn2) or urocortin 3 (Ucn3) affects manifestations of PTSD in a single prolonged stress (SPS) animal model of PTSD. Elevated plus maze (EPM) and open field (OF) tests were used to assess anxiety-like behavior. Changes in the gene expressions of CRH, CRHR1, CRHR2, glucocorticoid receptor (GR), and FKBP5 were measured in brain regions (BNST, amygdala, and PVN) responsible for modulating the stress response. The SPS animals spent less time in the OF central zone and were less mobile than the controls; however, the Ucn3 treatment reversed this effect. SPS decreased the GR and FKPB5 mRNA levels in the PVN. Ucn3 suppressed the effect of SPS on FKBP5 mRNA expression in the PVN and increased FKBP5 mRNA in the BNST and PVN compared to the stressed animals. We demonstrate that Ucn3 has the potential to ameliorate anxiety-like behavior in SPS animals and also to affect the neuroendocrine system in the BNST and PVN. In addition, we confirm the important role of CRHR2 signaling in mediating the stress response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Research Center of the Slovak Academy of Sciences, Institute of Experimental Endocrinology, 845 05 Bratislava, Slovakia.
- Centre of Experimental Medicine of the Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, 841 04 Bratislava, Slovakia.
- Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Comenius University Bratislava, 842 15 Bratislava, Slovakia.
ORCID-Profile: Andrej Tillinger, Mojmír Mach, Jana Osacká
Förderung
- VEGA
Zitieren
APA
Tillinger, A., Zvozilová, A., Mach, M., Horváthová, Ľ., Dziewiczová, L., & Osacká, J. (2024). Single Intranasal Administration of Ucn3 Affects the Development of PTSD Symptoms in an Animal Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211908
Vancouver
Tillinger A, Zvozilová A, Mach M, Horváthová Ľ, Dziewiczová L, Osacká J. Single Intranasal Administration of Ucn3 Affects the Development of PTSD Symptoms in an Animal Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211908
BibTeX
@article{Tillinger2024,
author = {Tillinger, Andrej and Zvozilová, Alexandra and Mach, Mojmír and Horváthová, Ľubica and Dziewiczová, Lila and Osacká, Jana},
title = {Single Intranasal Administration of Ucn3 Affects the Development of PTSD Symptoms in an Animal Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211908}
}
EUVIMED